Plasma Adiponectin Levels in Elderly Patients with Prediabetes

Area of Science:

• Gerontology
• Endocrinology
• Metabolic Syndrome Research

Background:

• The role of adiponectin in elderly individuals with prediabetes remains unclear.
• Prediabetes affects a significant portion of the elderly population, increasing their risk for type 2 diabetes and cardiovascular disease.

Purpose of the Study:

• To investigate the relationship between adiponectin levels and anthropometric variables in elderly prediabetic patients.
• To assess the association of adiponectin with body composition, insulin sensitivity, and lipid profiles in this demographic.

Main Methods:

• Study included 120 elderly prediabetic subjects (>65 years) from the Korea Rural Genomic Cohort Study.
• Participants underwent an oral glucose tolerance test and insulin sensitivity assessments.
• Prediabetes diagnosis adhered to American Diabetes Association criteria.

Main Results:

• Elderly prediabetic subjects had lower plasma adiponectin than those with normal glucose tolerance.
• Prediabetic patients with metabolic syndrome (MetS) showed lower adiponectin levels compared to those without MetS.
• Higher plasma adiponectin levels were associated with lower waist-to-hip ratio and 2-hour insulin levels.
• Adiponectin levels inversely correlated with body mass index (BMI), waist circumference (WC), visceral fat, and insulin levels.

Conclusions:

• Key factors correlating with adiponectin levels in elderly prediabetics include BMI, WC, waist-to-hip ratio, visceral fat, and insulin sensitivity.
• Adiponectin may serve as a biomarker for metabolic health in aging populations with prediabetes.